Home > Drugs A – Z > Gadofosveset (By injection)

Gadofosveset (By injection)

Used in magnetic resonance angiography (MRA) scans. Helps your doctor to see images of your blood vessels (arteries). This medicine is a gadolinium-based contrast agent (GBCA).

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Gadofosveset is a contrast agent. It is used in magnetic resonance angiography (MRA) to help create a clear picture of the blood vessels (arteries). The MRA scan is a special kind of diagnostic procedure. It uses magnets and computers to create images or “pictures” of the blood vessels in certain areas of the body. Gadofosveset is a gadolinium-based contrast agent (GBCA). Gadofosveset is given by… Read more
Brand names include
Ablavar
Drug classes About this
Diagnostic Agent, Radiological Contrast Media

What works? Research summarized

Evidence reviews

Lower Limb Peripheral Arterial Disease: Diagnosis and Management [Internet]

Lower limb peripheral arterial disease (known in the document as peripheral arterial disease, PAD) is a marker for an increased risk of potentially preventable cardiovascular events even when it is asymptomatic. If it becomes symptomatic it can lead to significant impairment of quality of life through limiting mobility and in its more severe manifestations may lead to severe pain, ulceration and gangrene and is the largest single cause of lower limb amputation in the UK.

Vulnerable Atherosclerotic Plaque [Internet]

Over the past two decades, the concept of the “vulnerable plaque” has gained attention as a paradigm to improve risk stratification and potentially lead to newer invasive and non-invasive therapeutic options to prevent and treat atherothrombotic cardiovascular disease. The Effective Health Care Program at the Agency for Healthcare Research & Quality requested a technical brief on the diagnosis and treatment of “vulnerable plaques” of coronary and carotid arteries. Our report is based on a set of key questions designed to explore the concept of “vulnerable plaque” and how this concept could affect the use of existing or developing diagnostic and therapeutic technologies. This report also expands on a technical report on vulnerable plaque that we conducted in 2004.

PubMed Health Blog...

read all...